Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial

Read, JA; Beale, PJ; Volker, D; Smith, NF; Childs, A; Clarke, SJ

Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial

Read, JA Beale, PJ Volker, D Smith, NF Childs, A Clarke, SJ

Permalink

Publisher:: Springer
Publication Type:: Journal Article
Citation:: Supportive Care In Cancer, 2007, 15 (3), pp. 301 - 307
Issue Date:: 2007-01

Closed Access

	Filename	Description	Size
	2006011479.pdf		476.69 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Read, JA	en_US
dc.contributor.author	Beale, PJ	en_US
dc.contributor.author	Volker, D	en_US
dc.contributor.author	Smith, NF	en_US
dc.contributor.author	Childs, A	en_US
dc.contributor.author	Clarke, SJ	en_US
dc.date.issued	2007-01	en_US
dc.identifier.citation	Supportive Care In Cancer, 2007, 15 (3), pp. 301 - 307	en_US
dc.identifier.issn	0941-4355	en_US
dc.identifier.uri	http://hdl.handle.net/10453/4409
dc.description.abstract	Goals The aim of the study was to assess the impact of an eicosapentanoic acid-containing protein and energy dense oral nutritional supplement (EPA-ONS) on nutritional and inflammatory status, quality of life (QOL), plasma phospholipids (PPL) and cytokin	en_US
dc.publisher	Springer	en_US
dc.relation.ispartof	Supportive Care In Cancer	en_US
dc.relation.isbasedon	10.1007/s00520-006-0153-3	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.title	Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial	en_US
dc.type	Journal Article
utslib.citation.volume	3	en_US
utslib.citation.volume	15	en_US
utslib.location.activity	ISI:000243816900005	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	11 Medical And Health Sciences	en_US
utslib.for	17 Psychology And Cognitive Sciences	en_US
dc.location.activity	ISI:000243816900005	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Mathematical Sciences
utslib.copyright.status	closed_access
pubs.consider-herdc	true	en_US
pubs.issue	3	en_US
pubs.volume	15	en_US

Abstract:

Goals The aim of the study was to assess the impact of an eicosapentanoic acid-containing protein and energy dense oral nutritional supplement (EPA-ONS) on nutritional and inflammatory status, quality of life (QOL), plasma phospholipids (PPL) and cytokin

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/4409